S R. Ande, et.al., Expression of a mutant prohibitin from the aP2 gene promoter leads to obesity-linked tumor development in insulin resistance-dependent manner., Oncogene, 2016, 35

http://rdf.ncbi.nlm.nih.gov/pubmed/26751773

S R. Ande, et.al., Expression of a mutant prohibitin from the aP2 gene promoter leads to obesity-linked tumor development in insulin resistance-dependent manner., Oncogene, 2016, 35

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Tg(Fabp4-Phb*Y114F)#Smis
  http://metadb.riken.jp/db/mgi_rdf/MGI:5763309

class

http://purl.org/net/cito/citesAsAuthority

• Tg(Fabp4-Phb*Y114F)#Smis
  http://metadb.riken.jp/db/mgi_rdf/MGI:5763309

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• decreased circulating ghrelin level_Tg(Fabp4-Phb*Y114F)#Smis/0
  http://metadb.riken.jp/0011613NSTgFabp4PhbY114FSmis0TgFabp4PhbY114FSmis
• abnormal circulating chemokine level_Tg(Fabp4-Phb*Y114F)#Smis/0
  http://metadb.riken.jp/0010209NSTgFabp4PhbY114FSmis0TgFabp4PhbY114FSmis
• impaired glucose tolerance_Tg(Fabp4-Phb*Y114F)#Smis/0
  http://metadb.riken.jp/0005293NSTgFabp4PhbY114FSmis0TgFabp4PhbY114FSmis
• increased tumor incidence_Tg(Fabp4-Phb*Y114F)#Smis/0
  http://metadb.riken.jp/0002020NSTgFabp4PhbY114FSmis0TgFabp4PhbY114FSmis
• increased circulating insulin-like growth factor I level_Tg(Fabp4-Phb*Y114F)#Smis/0
  http://metadb.riken.jp/0004702NSTgFabp4PhbY114FSmis0TgFabp4PhbY114FSmis
• abnormal spleen morphology_Tg(Fabp4-Phb*Y114F)#Smis/0
  http://metadb.riken.jp/0000689NSTgFabp4PhbY114FSmis0TgFabp4PhbY114FSmis
• increased lymphocyte cell number_Tg(Fabp4-Phb*Y114F)#Smis/0
  http://metadb.riken.jp/0005013NSTgFabp4PhbY114FSmis0TgFabp4PhbY114FSmis
• abnormal lymph node morphology_Tg(Fabp4-Phb*Y114F)#Smis/0
  http://metadb.riken.jp/0002339NSTgFabp4PhbY114FSmis0TgFabp4PhbY114FSmis
• insulin resistance_Tg(Fabp4-Phb*Y114F)#Smis/0
  http://metadb.riken.jp/0005331NSTgFabp4PhbY114FSmis0TgFabp4PhbY114FSmis
• increased circulating ghrelin level_Tg(Fabp4-Phb*Y114F)#Smis/0
  http://metadb.riken.jp/0011612NSTgFabp4PhbY114FSmis0TgFabp4PhbY114FSmis
• increased adiponectin level_Tg(Fabp4-Phb*Y114F)#Smis/0
  http://metadb.riken.jp/0004892NSTgFabp4PhbY114FSmis0TgFabp4PhbY114FSmis
• obese_Tg(Fabp4-Phb*Y114F)#Smis/0
  http://metadb.riken.jp/0001261NSTgFabp4PhbY114FSmis0TgFabp4PhbY114FSmis
• enlarged lymph nodes_Tg(Fabp4-Phb*Y114F)#Smis/0
  http://metadb.riken.jp/0000702NSTgFabp4PhbY114FSmis0TgFabp4PhbY114FSmis
• abnormal circulating cytokine level_Tg(Fabp4-Phb*Y114F)#Smis/0
  http://metadb.riken.jp/0010210NSTgFabp4PhbY114FSmis0TgFabp4PhbY114FSmis
• abnormal glucose homeostasis_Tg(Fabp4-Phb*Y114F)#Smis/0
  http://metadb.riken.jp/0002078NSTgFabp4PhbY114FSmis0TgFabp4PhbY114FSmis
• enlarged spleen_Tg(Fabp4-Phb*Y114F)#Smis/0
  http://metadb.riken.jp/0000691NSTgFabp4PhbY114FSmis0TgFabp4PhbY114FSmis
• increased circulating leptin level_Tg(Fabp4-Phb*Y114F)#Smis/0
  http://metadb.riken.jp/0005669NSTgFabp4PhbY114FSmis0TgFabp4PhbY114FSmis
• increased circulating insulin level_Tg(Fabp4-Phb*Y114F)#Smis/0
  http://metadb.riken.jp/0002079NSTgFabp4PhbY114FSmis0TgFabp4PhbY114FSmis